All Blogs

Nov 29, 2024

According to the World Health Organization (WHO), in 2022, there were approximately 2.5 million new cases of lung cancer globally, which accounted for 12.4% of all newly diagnosed cancer cases. Lung cancer continues to be one of the most common and deadly malignancies worldwide, with significant contributions to gl...

Oct 31, 2019

AstraZeneca has announced the licensing-out of two of its drugs Seroquel and Seroquel XR in Europe and Russia to Cheplapharm Arzneimittel GmbH. According to the deal signed between the companies, AZ will receive an upfront payment of USD 178 Million, in addition to other payments upon achieving sales milestones...

Oct 30, 2019

Geographic atrophy (GA) is a severe, progressive, irreversible vision loss in old age people. The loss in the vision is due to the damage in a small portion of the retina at the back of the eye, known as the macula. Since the loss of vision is due to age, it is also referred to as Age-related macular degeneration. ...

Oct 29, 2019

World Psoriasis Day, observed on 29th October every year to raise awareness globally and spread information about psoriasis and psoriatic arthritis. Psoriasis generally occurs from an overactive immune system resulting in skin rashes. Around 0.5-2.8% of the Indian population is affected by this disease. Psoriasis c...

Oct 29, 2019

AstraZeneca recently has announced the results of the clinical trials POSEIDON which included the study of a combination of drugs Imfinzi (durvalumab) and tremelimumab with chemotherapy in lung cancer. Imfinzi is a human monoclonal antibody which blocks the interaction of PD-L1 with PD-1 by binding itself with ...

Oct 28, 2019

The cases of Melanoma have been on a hike for the past thirty years making it the fifth most common cancer among people. By the end of the year 2019, an estimated number of 57,220 men and 39,260 women in the United States would have been diagnosed with invasive melanoma, as per Cancer.net. Melanoma is the rarest...

Oct 25, 2019

A very common, although not a life-threatening fungal infection of the nail, Onychomycosis is regarded as a serious health problem because of increasing global prevalence. According to a study by P. Dyanne et al, Onychomycosis occurs in 10% of the general population but is more common in older adults; the preva...

Oct 24, 2019

Rapt Therapeutics files for IPO at $75M Rapt Therapeutics, based in the US, filed to raise to $75 million in its IPO. This had come after five months when the company had retitled itself, which was earlier known as Flx Bio and after three months, it had filed its initial S-1 form with the hope to gain $86 millio...

Oct 23, 2019

Not a long time ago this year, Biogen announced the halting of Phase III clinical trials, EMERGE and ENAGE, of its most looked upon drug aducanumab under simulations for the treatment of Alzheimer's disease called futility analysis. The drug was designed to help patients struggling with mild cognitive impairmen...

Oct 22, 2019

The US FDA today has given its nod to Trikafta (elexacaftor/ivacaftor/tezacaftor) of Vertex Pharmaceuticals, the first of its kind triple combination therapy for the patients with cystic fibrosis. The drug, Trikafta, has been approved for patients of age 12 years and older who have at least one F508del mutation...